Western blot and q-PCR results also showed that emodin downregulated the intracellular protein expression levels of SREBP-1c, ACC1, FASN, and ACLY (Figure 7C–7K), which was in accordance with the effects of PRPM treatment in the livers of the NAFLD model mice. This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.